Issued Patents 2022
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11535866 | Gene therapy for treating citrullenemia | Jenny Agnes Sidrane, Lili Wang | 2022-12-27 |
| 11535665 | AAV-mediated expression of anti-influenza antibodies and methods of use thereof | Maria P. Limberis, Anna P. Tretiakova | 2022-12-27 |
| 11499167 | Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby | Guangping Gao, Mauricio R. Alvira | 2022-11-15 |
| 11473106 | Gene therapy for treating Wilson's disease | Jenny Agnes Sidrane, Lakshmanan Govindasamy | 2022-10-18 |
| 11401527 | Compositions and methods useful for prophylaxis of organophosphates | Anna P. Tretiakova | 2022-08-02 |
| 11396663 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor | Guangping Gao, Mauricio R. Alvira | 2022-07-26 |
| 11390883 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor | Guangping Gao, Mauricio R. Alvira | 2022-07-19 |
| 11382941 | Gene therapy for treating Phenylketonuria | Jenny Agnes Sidrane, Scott Ashley | 2022-07-12 |
| 11377669 | Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby | Guangping Gao, Mauricio R. Alvira | 2022-07-05 |
| 11377641 | Scalable production method for AAV | Martin Lock, Luc H. Vandenberghe | 2022-07-05 |
| 11357868 | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor | Guangping Gao, Mauricio R. Alvira, Luc H. Vandenberghe | 2022-06-14 |
| 11357867 | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor | Guangping Gao, Mauricio R. Alvira, Luc H. Vandenberghe | 2022-06-14 |
| 11253612 | Gene therapy for treating mucopolysaccharidosis type II | Christian Hinderer | 2022-02-22 |
| 11241506 | Composition for treatment of Crigler-Najjar syndrome | Anna P. Tretiakova, Jenny Agnes Sidrane | 2022-02-08 |